Recent

% | $
Quotes you view appear here for quick access.

Amgen Inc. Message Board

  • ron.wallach ron.wallach May 13, 2013 11:44 PM Flag

    PROVENGE® (sipuleucel-T) is approved by the FDA as an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.

     

    dndn buyout may happen

    Sentiment: Strong Buy

    This topic is deleted.
 
AMGN
147.02-2.21(-1.48%)Sep 4 4:00 PMEDT